Country/Product Brief

Country/product Brief

Abstract

This study will focus on globalization strategy of an Indian pharmaceutical company. This study will analyze market entry strategy and an opportunity lies in USA pharmaceutical market for an Indian pharmaceutical company. Organization selected for the study is Lupin Ltd which is an Indian MNC catering more than 70 countries across the globe. This study will show the market environment of USA and entry opportunities for Lupin in USA market and best suited marketing strategy for Lupin to cater USA market. This study will also focus on the competition level in pharmaceutical market and future prospect for Lupin to establish itself in the USA market as a pharmaceutical giant.

Table of Contents

External Environment 4

Political 4

Economic 5

Social 6

Technology 6

Environment 6

Legal 6

Customer segments 7

Marketing Strategy of Lupin in USA 7

Market entry opportunities & Barriers 8

Channels of distribution 9

Competitive threats 9

Conclusion 10

References 11

Pharmaceutical Market

Global pharmaceutical market is valued of 484,151million Euros but more than 47% of market share is dominated by USA alone. Almost 370 different drugs have been discovered by USA pharmaceutical industry in last decade and 50% of drugs in the area of heart disease or hypertension, Alzheimer’s disease, arthritis, Parkinson’s, cancer are manufactured by USA pharmaceutical industry alone. Top USA pharmaceutical companies like Eli Lily, Pfizer, Bristol-Myers Squibb, Genzyme, Amgen, Genentech, Biogen and Johnson & Johnson are also world leader in their respected field (Economy Watch, 2010).

USA pharmaceutical market is a competitive in terms of growth opportunity and number of pharmaceutical companies is trying to win market share. The Organization selected for study is Lupin Limited.

Lupin which is one of Ivy League pharmaceutical company in India and also known for...